BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6132457)

  • 1. Mutagenicity of a series of 25 nitroimidazoles and two nitrothiazoles in Salmonella typhimurium.
    Cantelli-Forti G; Aicardi G; Guerra MC; Barbaro AM; Biagi GL
    Teratog Carcinog Mutagen; 1983; 3(1):51-63. PubMed ID: 6132457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mutagenic activity of nitrothiazole compounds].
    Hof H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Jun; 181(1-2):64-70. PubMed ID: 3901605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic activity of 4 active-principle forms of pharmaceutical drugs. Comparative study in the Salmonella typhimurium microsome test, and the HGPRT and Na+/K+ ATPase systems in cultured mammalian cells.
    Dayan J; Crajer MC; Deguingand S
    Mutat Res; 1982; 102(1):1-12. PubMed ID: 6289090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of nitroimidazo (2,1-b) thiazoles in the Salmonella mutagenicity assay.
    Biagi GL; Hrelia P; Guerra MC; Paolini M; Barbaro AM; Cantelli-Forti G
    Arch Toxicol Suppl; 1986; 9():425-9. PubMed ID: 3545148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direct-acting mutagenicity of nitroimidazo[2,1-b]thiazoles in Salmonella typhimurium.
    Hrelia P; Paolini M; Biagi GL; Cantelli-Forti G
    Teratog Carcinog Mutagen; 1986; 6(6):511-9. PubMed ID: 2881366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.
    Lindmark DG; Müller M
    Antimicrob Agents Chemother; 1976 Sep; 10(3):476-82. PubMed ID: 791102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of nitrofurans, nitrothiophenes, nitropyrroles, nitroimidazole, aminothiophenes, and aminothiazoles in Salmonella typhimurium.
    Wang CY; Muraoka K; Bryan GT
    Cancer Res; 1975 Dec; 35(12):3611-7. PubMed ID: 1104157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capacity of some nitro- and amino-heterocyclic sulfur compounds to induce base-pair substitutions.
    Voogd CE; van der Stel JJ; Verharen HW
    Mutat Res; 1983 Aug; 118(3):153-65. PubMed ID: 6348526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for the mutagenicity of nitro-group containing hypoxic cell radiosensitizers using Salmonella typhimurium strains TA 100 and TA98.
    Chin JB; Sheinin DM; Rauth AM
    Mutat Res; 1978 Sep; 58(1):1-10. PubMed ID: 362190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenic activity of radiosensitizers.
    Grzybowska E; Kalinowska E; Szala S
    Acta Microbiol Pol; 1985; 34(2):111-20. PubMed ID: 2412398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural alterations that differentially affect the mutagenic and antitrichomonal activities of 5-nitroimidazoles.
    Walsh JS; Wang R; Bagan E; Wang CC; Wislocki P; Miwa GT
    J Med Chem; 1987 Jan; 30(1):150-6. PubMed ID: 3543363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity study on pyrazole, seven pyrazole derivatives, and two nitroimidazoles with the L-arabinose resistance test of Salmonella typhimurium.
    Alejandre-Durán E; Ruiz-Rubio M; Claramunt RM; López C; Pueyo C
    Environ Mutagen; 1986; 8(4):611-9. PubMed ID: 3525137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutagenic action of nitroimidazoles. IV. A comparison of the mutagenic action of several nitroimidazoles and some imidazoles.
    Voogd CE; van der Stel JJ; Jacobs JJ
    Mutat Res; 1979 Mar; 66(3):207-21. PubMed ID: 375080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of GO 10213, a nitroimidazole derivative.
    Hof H; Ströder J
    Antimicrob Agents Chemother; 1986 May; 29(5):953-4. PubMed ID: 3729357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of genotype on mutagenicity of niridazole in nitroreductase-deficient bacteria.
    Speck WT; Blumer JL; Rosenkranz EJ; Rosenkranz HS
    Cancer Res; 1981 Jun; 41(6):2305-7. PubMed ID: 7016312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagen screening with bacteria: niridazole and nitrofurans.
    McCalla DR; Voutsinos D; Olive PL
    Mutat Res; 1975 Feb; 31(1):31-7. PubMed ID: 1093013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mutagenicity of nitroimidazoles.
    Voogd CE
    Mutat Res; 1981 May; 86(3):243-77. PubMed ID: 6457989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice.
    Legator MS; Connor TH; Stoeckel M
    Science; 1975 Jun; 188(4193):1118-9. PubMed ID: 766186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic activities of nitrothiazole derivatives in experimental infections with Salmonella typhimurium and Bacteroides fragilis.
    Hof H; Eisenbarth B; Denzler A; Zak O; Schweizer E
    J Antimicrob Chemother; 1985 Aug; 16(2):205-10. PubMed ID: 3905749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.
    Hof H; Rieffert M; Sticht-Groh V; Zak O; Schweizer EH
    Antimicrob Agents Chemother; 1984 Oct; 26(4):498-500. PubMed ID: 6517542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.